Table 2 Comparison of Q-plex™ technology to traditional ELISA assays
From: Simultaneous multi-analyte urinary protein assay for bladder cancer detection
Q-plex™ array | Commercial ELISA assay | |||
|---|---|---|---|---|
Cancer | Benign | Cancer | Benign | |
IL8 (pg/ml) | ||||
Median | 127.7 | 2.2 | 100.8 | 144.3 |
(Min, Max) | (0.4, 5,087.5) | (0.5, 185.3) | (0, 4,355.3) | (0, 506.3) |
Mean ± SD* | 423.6 ± 931.2 | 14.6 ± 40.9 | 276.8 ± 768.9 | 180.0 ± 138.2 |
MMP9 (pg/ml) | ||||
Median | 268,688 | 248,730.5 | 2,833.2 | 545.3 |
(Min, Max) | (176,103.9, 3,783,990.1) | (162,655.6, 867,918.5) | (0, 12,988.9) | (0, 7,146) |
Mean + SD | 469,075.4 ± 655,960.4 | 320,746.6 ± 171,092.6 | 5,236.0 ± 4,144.5 | 876.5 ± 1,353.0 |
VEGFA (pg/ml) | ||||
Median | 12,599.4 | 12,677.5 | 143.6 | 19.5 |
(Min, Max) | (2,093.3, 498,114.9) | (810.1, 262,356.7) | (1.1, 9,874.1) | (0, 184.2) |
Mean + SD | 33,483.5 ± 88,403.7 | 20,690.5 ± 39,702.7 | 1061.6 ± 2132.9 | 36.2 ± 47.4 |